机构:[1]The Department of Anesthesiology, Pain and Perioperative Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China[2]The Department ofAnesthesiology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China[3]Department of Medical Iconography, The Second Affiliated HospitalUniversity of Guangzhou Traditional Chinese Medicine, Guangzhou, Guangdong, China[4]Department of Liver Diseases, Fifth Medical Center of Chinese PLA General Hospital,Beijing, China
National Natural Science Foundation of China (grant
numbers 81671957 and 81873951), key projects of Guangdong Natural Science
Foundation, China (grant number 2018B030311038), and Science and Technology
Planning Project of Guangdong Province, China (grant number 2014A020212268).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类|2 区医学
小类|3 区细胞生物学
最新[2025]版:
大类|2 区生物学
小类|2 区细胞生物学
第一作者:
第一作者机构:[1]The Department of Anesthesiology, Pain and Perioperative Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Xue Qiong,Liu Xiaolei,Chen Cuiping,et al.Erlotinib protests against LPS-induced parthanatos through inhibiting macrophage surface TLR4 expression.[J].Cell death discovery.2021,7(1):181.doi:10.1038/s41420-021-00571-4.
APA:
Xue Qiong,Liu Xiaolei,Chen Cuiping,Zhang Xuedi,Xie Pengyun...&Tang Jing.(2021).Erlotinib protests against LPS-induced parthanatos through inhibiting macrophage surface TLR4 expression..Cell death discovery,7,(1)
MLA:
Xue Qiong,et al."Erlotinib protests against LPS-induced parthanatos through inhibiting macrophage surface TLR4 expression.".Cell death discovery 7..1(2021):181